You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CR845

Showing 1 - 25 of 197
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pruritus, Notalgia Paresthetica Trial in Coral Gables (difelikefalin 2.0 mg tablets, difelikefalin 1.0 mg tablets, difelikefalin

Recruiting
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg tablets
  • +3 more
  • Coral Gables, Florida
    Cara Therapeutics Study Site
Aug 3, 2023

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Northridge, California
  • +5 more
Dec 21, 2022

Pruritus, Atopic Dermatitis Trial in Canada, United States (difelikefalin 0.25 mg, difelikefalin 0.5 mg, difelikefalin 1.0 mg)

Completed
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +3 more
  • Anniston, Alabama
  • +39 more
Mar 30, 2022

Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)

Completed
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg
  • Placebo
  • Fort Smith, Arkansas
  • +35 more
Aug 1, 2022

Uremic Pruritus Trial in Worldwide (CR845 0.5 mcg/kg)

Completed
Has Results
  • Uremic Pruritus
  • CR845 0.5 mcg/kg
  • Escondido, California
  • +46 more
Sep 21, 2021

Uremic Pruritus Trial in Puerto Rico, United States (CR845)

Completed
Has Results
  • Uremic Pruritus
  • CR845
  • Chula Vista, California
  • +26 more
Sep 21, 2021

Pruritus, Atopic Dermatitis Trial (difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream)

Recruiting
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +4 more
  • Scottsdale, Arizona
  • +36 more
Dec 21, 2022

Uremic Pruritus Trial in United States (CR845 0.5 mcg/kg, CR845 1 mcg/kg, CR845 1.5mcg/kg)

Completed
Has Results
  • Uremic Pruritus
  • CR845 0.5 mcg/kg
  • +3 more
  • Phoenix, Arizona
  • +28 more
Jul 15, 2020

Osteoarthritis, Hip, Osteoarthritis, Knee, Arthritis Trial in United States (CR845 tablet 1 mg, CR845 tablet 2.5 mg, CR845

Completed
Has Results
  • Osteoarthritis, Hip
  • +5 more
  • CR845 tablet 1 mg
  • +3 more
  • Birmingham, Alabama
  • +34 more
Oct 19, 2020

Healthy Trial in Dallas (CR845 0.5 mcg/kg IV, CR845 3 mcg/kg IV, Moxifloxacin 400 mg Oral Tablet)

Completed
  • Healthy
  • CR845 0.5 mcg/kg IV
  • +3 more
  • Dallas, Texas
    Cara Therapeutics Study Site
Feb 20, 2020

Chronic Kidney Diseases, Pruritus Trial in United States (CR845 0.25 mg Oral Tablet, CR845 0.5 mg Oral Tablet, CR845 1 mg Oral

Completed
  • Chronic Kidney Diseases
  • Pruritus
  • CR845 0.25 mg Oral Tablet
  • +3 more
  • Birmingham, Alabama
  • +59 more
Oct 22, 2020

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Huntsville, Alabama
  • +51 more
Dec 21, 2022

Hemodialysis, Healthy Trial in San Antonio ([14C] CR845)

Completed
  • Hemodialysis
  • Healthy
  • [14C] CR845
  • San Antonio, Texas
    Cara Therapeutics Study Site
Jul 23, 2019

Post Abdominal Surgery Pain Trial in United States (CR845 IV 1 mcg/kg, CR845 IV 0.5 mcg/kg, Placebo IV)

Completed
  • Post Abdominal Surgery Pain
  • CR845 IV 1 mcg/kg
  • +2 more
  • Sheffield, Alabama
  • +22 more
May 22, 2019

Melanoma, NSCLC, Colorectal Cancer Trial in United States (LYL845)

Recruiting
  • Melanoma
  • +2 more
  • LYL845
  • Columbus, Ohio
  • +3 more
Dec 19, 2022

a High Probability of Meeting Eligibility Criteria

Recruiting
  • Alzheimer Disease
  • +4 more
  • Prescreener database
  • San Diego, California
  • +18 more
Dec 28, 2022

Esophageal Cancer, Gastric Cancer, Adenocarcinoma Trial in United States (Niraparib)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Tampa, Florida
  • +3 more
Jan 18, 2023

Exactech Guided Personalized Surgery and Conventional

Recruiting
  • Technology
  • Comparison
    • New York, New York
    • +1 more
    Nov 7, 2022

    Exercise Sensitivity, Introceptive Exposure, Anxiety Trial in East Brunswick, New Brunswick (Behavioral Exposure For

    Recruiting
    • Exercise Sensitivity
    • +3 more
    • Behavioral Exposure For Introceptive Tolerance
    • Health Education Control
    • East Brunswick, New Jersey
    • +1 more
    May 26, 2022

    Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

    Recruiting
    • Rectal Neoplasms
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Aug 27, 2023

    Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • +3 more
    • Gilbert, Arizona
    • +14 more
    Apr 20, 2022

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

    Recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Gemtuzumab Ozogamicin
    • +4 more
    • Baltimore, Maryland
    • +1 more
    Dec 13, 2022

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Tracheostomy Weaning Trial in Sherbrooke (Suctioning based protocol, Usual Care)

    Not yet recruiting
    • Tracheostomy Weaning
    • Suctioning based protocol
    • Usual Care
    • Sherbrooke, Quebec, Canada
      Université de Sherbrooke
    Mar 9, 2023

    Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

    Recruiting
    • Urinary Bladder Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023